Pegfilgrastim is a hematopoietic agent used to treat neutropenia, a condition characterized by low white blood cell counts. It stimulates the bone marrow to produce more white blood cells, thereby reducing the risk of infections. Pegfilgrastim is often used in cancer patients undergoing chemotherapy. Common side effects may include bone pain and injection site reactions, but these typically resolve over time. In summary, Pegfilgrastim is vital for boosting white blood cell counts and supporting immune function.
Pegfilgrastim stimulates the proliferation and differentiation of hematopoietic progenitor cells in the bone marrow, increasing white blood cell production.
No published brands for this salt yet.